山東路橋(000498.SZ):重組事項19日上會 當天停牌
格隆匯8月13日丨山東路橋(000498.SZ)公佈,2020年8月13日,中國證監會在官網公佈了《併購重組委2020年第33次工作會議公告》,中國證監會上市公司併購重組委定於2020年8月19日上午9:00召開2020年第33次併購重組委工作會議,對公司發行股份購買資產並募集配套資金暨關聯交易事項進行審核。公司已向中國證監會上市公司監管部出具了《山東高速路橋集團股份有限公司保證不影響和干擾併購重組委審核的承諾函》。
公司將在併購重組委工作會議召開當日申請股票停牌,並在併購重組委審核結果公佈後,及時履行信息披露義務並申請股票復牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.